Stem cells show signal of benefit in microvascular dysfunction
Autologous CD34-positive stem cells may improve coronary flow reserve and angina symptoms in patients with microvascular dysfunction, proof-of-concept testing suggests. Evidence of microvascular dysfunction is present in about 50% to 70% of patients with ischemia and no obstructive coronary artery disease, a rapidly growing patient population that is disproportionately female and has an elevated risk for major cardiovascular events.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063